Viewing Study NCT01026051


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2025-12-30 @ 9:39 AM
Study NCT ID: NCT01026051
Status: TERMINATED
Last Update Posted: 2012-05-15
First Post: 2009-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma
Sponsor: Mannkind Corporation
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-10
Start Date Type: None
Primary Completion Date: 2011-09
Primary Completion Date Type: ACTUAL
Completion Date: 2012-07
Completion Date Type: ESTIMATED
First Submit Date: 2009-12-03
First Submit QC Date: None
Study First Post Date: 2009-12-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2012-05-10
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2012-05-10
Last Update Post Date: 2012-05-15
Last Update Post Date Type: ESTIMATED